Molecular Assemblies Recognized as a Leader in Innovation

Molecular Assemblies - Leader in Innovation

SAN DIEGO, CA. — Aug. 4, 2017— Molecular Assemblies Inc., a company developing a proprietary enzymatic DNA synthesis technology, was recognized today as a leader in innovation in San Diego by CONNECT and San Diego Mayor Kevin L. Faulconer during an event unveiling CONNNECTs annual San Diego Innovation Report. Molecular Assemblies was one of 20 companies spotlighted in the report out of 1,600 start-ups over the past three years.

“We are thrilled to be recognized by CONNECT and Mayor Faulconer as a leader in innovation in San Diego,” said Molecular Assemblies President and CEO Michael J. Kamdar. “San Diego continues to be a one of the most vital regions nationwide in the life sciences. As an early stage company, we appreciate the support of organizations such as CONNECT and a local environment that fosters entrepreneurship and innovation.”

The 2016 CONNECT Innovation Report notes that innovation sector now accounts for a quarter of San Diego’s total gross domestic product. The report also shows the continuation of a three-year trend in which San Diego has had more than 400 new startups each year, ranking San Diego County fourth in the state of California for new innovation startups created. The two most prevalent types of new innovation startups in 2016 were software with 255 companies created and life sciences with 82.

CONNECT is an innovation company accelerator in San Diego that helps entrepreneurs gain access to the resources they need for success. A full copy of the report is featured here. and the press conference viewed here.

About Molecular Assemblies

Molecular Assemblies, Inc. is a San Diego-based company focused on developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company’s patented enzymatic method, based on making DNA the way nature makes DNA, produces long, high quality, sequence-specific DNA reliably, affordably and sustainably. Molecular Assemblies’ technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines and bio-based electronics. For more information please visit